Skip to content

To study efficacy of Bramhi Ghrita in Mild Cognitive Impairment (Smrutimandya/ memory loss )

An Exploratory clinical trial to assess the efficacy of Brahmi Ghrita in Mild Cognitive impairment (MCI) - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056170
Enrollment
104
Registered
2023-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F70- Mild intellectual disabilities

Interventions

None listed

Sponsors

PDESs College of Ayurveda and Research Centre Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of either sex having age above 50 yrs. below 80yrs. 2) Patients having symptoms of Mild Cognitive impairment(MCI)

Exclusion criteria

Exclusion criteria: 1) Known case of Dementia, Alzheimerâ??s disease 2) Patients with evidence of delirium and other disturbances of consciousness 3) Patients having complications of major illness such as Liver/Kidney failure 4) Known case of Encephalopathy, Epileptic attacks, Coagulopathies, Neuromuscular diseases, Cancer, Stroke, intracranial hemorrhage, brain tumors and brain surgeries. 5) Patients using any type of psychotropic drugs. 6) Uncontrolled DM(HbA1C > 7.5) and its complications 7) Uncontrolled HTN (Systolic >160 &Diastolic >100) and itâ??s complications 8) Immunocompromised patients 9) patients having Hb 10) Patients having Dyslipidemia especially Sr Cholesterol >220 mg/dl, Sr Triglycerides > 180 mg/dl, Sr LDL > 150 mg/dl. 11) BMI > 40 and 12) Patients with physical impairment, such as walking, sitting, bladder and bowel incontinence

Design outcomes

Primary

MeasureTime frame
1) To evaluate efficacy of Brahmi Ghrita in Mild Cognitive impairment (MCI) in Elderly people.Timepoint: 1 week, 4 week, 8 week , 12 week

Secondary

MeasureTime frame
to study adverse drug reaction if anyTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Rupali Tarachand Khobragade

PDEAs College of Ayurveda and Research Centre Nigdi Pune

khobragaderupali19@gmail.com8378929859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026